Medius Associates
Medius provides an unrivalled range of specialised business development training solutions to cater for all levels of learning. This range extends from client specific in house tutorials through open enrolment courses to the Pharmaceutical Licensing Group’s distance learning modular MSc course.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Amiculum
AMICULUM works with the global healthcare industry to bring science to life across the product lifecycle from early opportunity assessment through to launch and beyond. By listening to the changing…
Dice Medical Communications
Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.
Impetus Digital
Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education to life science companies from around the globe since 2008.
OPEN Health
OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.
Company Details
Latest Content from PMHub
Article: Getting their lives back: Improving options for people with Lupus
White Papers and Resources | July 14, 2022 | Inizio
Head of Therapy Watch, Helen Parfitt and Head of Living With, Mariel Metcalfe, investigate Lupus from the perspective of both healthcare professionals and patients using data from our syndicated products.
HOW DID COVID-19 AFFECT PRESCRIBING BEHAVIOURS? FIVE KEY FINDINGS FROM A NEW STATE OF THE NATION REVIEW
Press Releases | July 14, 2022 | Wilmington Healthcare
Published earlier this month, Wilmington Healthcare’s new State of the Nation report draws on a raft of data from across primary and secondary care to show what actually happened to...
Accelerating patient recruitment post-COVID-19
White Papers and Resources | July 12, 2022 | Innovative Trials
COVID-19 has hugely affected clinical trials and patient recruitment, with the entire industry on hold for some time causing backlogs and delays most of the studies.
Genesis Research Acquires Market Access Transformation
Press Releases | July 11, 2022 | Genesis Research Group
Genesis Research, a leading provider of tech-enabled Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) services, has entered into a definitive agreement to acquire Market Access Transformation (“MAT”),...
Bedrock’s Accelerated Virtual Consensus Programme for Merck wins at Communiqué Awards
Press Releases | July 11, 2022 | Resonant Group
The award recognises outstanding achievement in flexing thinking and processes to ensure success.
ISPOR 2022: a retrospective
Videos and Podcasts | July 11, 2022 | Genesis Research Group
Genesis Research – an introduction
Videos and Podcasts | July 11, 2022 | Genesis Research Group
Traversing the Medtech Regulatory Landscape in the Interest of Patients
Videos and Podcasts | July 7, 2022 | Impetus Digital
Dr. Bassil Akra, CEO of AKRA TEAM GmbH, takes a deep dive into the new approval process for medical devices in the EU and shares how his company is supporting...